Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada

S. M. Mahmud et al.

http://wwwnc.cdc.gov/eid/article/24/7/16-1783

Source: Emerging Infectious Diseases Journal - May 22, 2018 Category: Infectious Diseases Source Type: research

More News: Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Canada Health | Flu Pandemic | H1N1 | Infectious Diseases | Influenza | Influenza Vaccine | Multiple Sclerosis | Pandemics | Study | Swine Flu (H1N1) Vaccine | Vaccines